THE PREVALENCE OF DYSPLASIA IN COLORECTAL SERRATED/HYPERPLASTIC POLYPS IN OMANI POPULATION
Abstract
Purpose: Serrated/hyperplastic polyps (SPs) are characterised histologically by sawtooth architecture. Historically, these polyps were considered benign, without malignant potential and thus clinically unimportant. At present, the WHO defines serrated/hyperplastic lesions as heterogeneous group, which include hyperplastic polyps (HP), sessile serrated adenoma (SSA)/polyp and traditional serrated adenoma (TSA). These can have malignant potential. The aim of this study was to evaluate the prevalence of dysplastic changes in SP of colon and rectum of Omani population reported at a tertiary care centre.
Methods: The study was conducted in the pathology department of a tertiary care centre including endoscopic polypectomies from colon and rectum of Omani patients presenting to gastroenterology clinic reported between 2014 and 2016, and these were analysed retrospectively for dysplastic changes and their association with different clinical parameters.
Results: Dysplasia was seen in 32 of 146 cases (21.9%) and 114 (78.1%) were without dysplasia. Of these dysplastic, biopsies’ only two cases (1.4%) showed high-grade dysplasia and rest 30 (20.5%) low-grade dysplasia. According to the type of polyp, dysplasia was found in TSA 8/21 cases (46.7%) and SSA 9/17 cases (53.3%). Association of dysplasia was more common in the age group of > 50 (15.07%) and male patients (62.5%).
Conclusion: SPs are now common findings that a gastroenterologist faces in their daily practice. In our study of Omani population, the prevalence of dysplasia is associated with older age group, male gender, SSA/polyp and traditional serrated adenoma.
Key words: Dysplasia. colorectal, polyps
References
Kumar VK, AbbasAC, Aster J. Robbins Basic Pathology. 9th ed. Philadelphia, PA: Saunders; 2013.
Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. J Clin Ultrasound 2014;9:1-6.
Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: Review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29.
Jouret-Mourin A, Geboes K. Serrated lesions of the colorectum, a new entity: What should a clinician/endoscopist know about it ? Acta Gastroenterol Belg 2012;75:197-202.
Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 2013;177:625-37.
Haque T, Greene KG, Crockett SD. Serrated neoplasia of the colon: What do we really know? Curr Gastroenterol Rep 2014;16:380.
Bettington ML, Chetty R. Traditional serrated adenoma: An update. Hum Pathol 2015;46:933-8.
Patai AV, Molnár B, Tulassay Z, et al. Serrated pathway: Alternative route to colorectal cancer. World J Gastroenterol 2013;19:607-15.
Qureshi A, Shihi SA, Ali Z, et al. A retrospective study of clinico-pathological characteristics of colonic polyps in adults seen at a tertiary care centre. J Pak Med Assoc 2017;67:12-4.
Cao HL, Chen X1, Du SC, et al. Detection Rate, distribution, clinical and pathological features of colorectal serrated polyps. Chin Med J 2016;129:2427-33.
Haque TR, Bradshaw PT, Crockett SD. Risk factors for serrated polyps of the colorectum. Dig Dis Sci 2014;59: 2874-89.
Orlowska J. Serrated lesions and hyperplastic (serrated) polyposis relationship with colorectal cancer: Classification and surveillance recommendations. Gastrointest Endosc 2013;7:858-71.
Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol 2013;11:760-7.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.
